Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level?
|
Am J Transplant
|
2015
|
2.24
|
2
|
Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting.
|
Transplantation
|
1999
|
1.70
|
3
|
Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients.
|
Am J Transplant
|
2011
|
1.69
|
4
|
Ethics of a paired-kidney-exchange program.
|
N Engl J Med
|
1997
|
1.66
|
5
|
Increased utilization of organ donors: transplantation of two recipients from single donor livers.
|
Transplant Proc
|
1990
|
1.61
|
6
|
Donor-transmitted malignancies in organ transplantation: assessment of clinical risk.
|
Am J Transplant
|
2011
|
1.59
|
7
|
Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation.
|
Transplantation
|
1998
|
1.36
|
8
|
Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients.
|
Am J Transplant
|
2010
|
1.31
|
9
|
Portal vein thrombosis and stenosis in pediatric liver transplantation.
|
Transplantation
|
1996
|
1.27
|
10
|
Immunosuppression and Merkel cell cancer.
|
Transplant Proc
|
2002
|
1.25
|
11
|
Posttransplant lymphoproliferative disorder: significance of central nervous system involvement.
|
Transplant Proc
|
2005
|
1.17
|
12
|
Liver transplantation for primary or metastatic sarcoma to the liver.
|
Am J Transplant
|
2006
|
1.16
|
13
|
Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.
|
Transplantation
|
1996
|
1.14
|
14
|
Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss.
|
Am J Transplant
|
2009
|
1.11
|
15
|
Complications in 100 living-liver donors.
|
Ann Surg
|
1998
|
1.07
|
16
|
Primary living-donor liver transplantation at the University of Chicago: technical aspects of the first 104 recipients.
|
Ann Surg
|
2000
|
1.01
|
17
|
Randomized controlled pilot study of B cell-targeted induction therapy in HLA sensitized kidney transplant recipients.
|
Am J Transplant
|
2013
|
0.97
|
18
|
The role of donor-specific HLA alloantibodies in liver transplantation.
|
Am J Transplant
|
2014
|
0.96
|
19
|
Biliary complications in living donor liver transplantation.
|
Transplant Proc
|
1997
|
0.95
|
20
|
Technetium-99m NGA functional hepatic imaging: preliminary clinical experience.
|
J Nucl Med
|
1985
|
0.94
|
21
|
Skin cancer following transplantation: the Israel Penn International Transplant Tumor Registry experience.
|
Transplant Proc
|
2005
|
0.93
|
22
|
A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience.
|
Transplant Proc
|
2005
|
0.92
|
23
|
Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression.
|
Transplant Proc
|
1998
|
0.91
|
24
|
Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I molecules.
|
J Immunol
|
1994
|
0.91
|
25
|
Comparison of pancreas transplantation with portal venous and enteric exocrine drainage to the standard technique utilizing bladder drainage of exocrine secretions.
|
Transplantation
|
1996
|
0.91
|
26
|
Efficacy of sotrastaurin plus tacrolimus after de novo kidney transplantation: randomized, phase II trial results.
|
Am J Transplant
|
2013
|
0.90
|
27
|
Analysis of fracture prevalence in kidney-pancreas allograft recipients.
|
J Am Soc Nephrol
|
1998
|
0.90
|
28
|
The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies.
|
J Am Soc Nephrol
|
1999
|
0.89
|
29
|
De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general population.
|
Transplant Proc
|
2005
|
0.88
|
30
|
Orthotopic liver transplantation in a patient with Amanita poisoning.
|
JAMA
|
1985
|
0.88
|
31
|
Laparoscopic living donor nephrectomy for kidneys with multiple arteries.
|
Transplant Proc
|
2005
|
0.88
|
32
|
Are concerns over right laparoscopic donor nephrectomy unwarranted?
|
Ann Surg
|
2001
|
0.87
|
33
|
Donor kidneys with small renal cell cancers: can they be transplanted?
|
Transplant Proc
|
2005
|
0.87
|
34
|
Helical CT examination of potential kidney donors.
|
AJR Am J Roentgenol
|
1998
|
0.87
|
35
|
Incompatible kidney donor candidates' willingness to participate in donor-exchange and non-directed donation.
|
Am J Transplant
|
2006
|
0.86
|
36
|
Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation.
|
Transplantation
|
1998
|
0.86
|
37
|
Drug-induced acute interstitial nephritis in renal allografts: histopathologic features and clinical course in six patients.
|
Am J Kidney Dis
|
1999
|
0.86
|
38
|
Laparoscopic right living donor nephrectomy.
|
Transplant Proc
|
2005
|
0.85
|
39
|
Polyomavirus in kidney and kidney-pancreas transplantation: a defined protocol for immunosuppression reduction and histologic monitoring.
|
Transplant Proc
|
2002
|
0.85
|
40
|
Gastric cancer in transplant recipients: detection of malignancy [correction of malignacy] by aggressive endoscopy.
|
Transplant Proc
|
2002
|
0.85
|
41
|
Primum non nocere: avoiding harm to vulnerable wait list candidates in an indirect kidney exchange.
|
Transplantation
|
2001
|
0.84
|
42
|
Ethical issues in increasing living kidney donations by expanding kidney paired exchange programs.
|
Transplantation
|
2000
|
0.84
|
43
|
Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection.
|
Transplantation
|
1994
|
0.84
|
44
|
De novo breast cancer in renal transplant recipients.
|
Transplant Proc
|
2002
|
0.84
|
45
|
Kinetic sensitivity of a receptor-binding radiopharmaceutical: technetium-99m galactosyl-neoglycoalbumin.
|
J Nucl Med
|
1989
|
0.83
|
46
|
Living related liver transplantation in children: a report of the first 58 recipients at the University of Chicago.
|
Transpl Int
|
1994
|
0.82
|
47
|
Proteasome inhibition reduces donor-specific antibody levels.
|
Transplant Proc
|
2009
|
0.82
|
48
|
Addressing morbid obesity as a barrier to renal transplantation with laparoscopic sleeve gastrectomy.
|
Am J Transplant
|
2015
|
0.81
|
49
|
Early steroid withdrawal does not increase risk for recurrent focal segmental glomerulosclerosis.
|
Transplant Proc
|
2005
|
0.81
|
50
|
Activation of human T cells in vivo following treatment of transplant recipients with OKT3.
|
Transplantation
|
1990
|
0.81
|
51
|
HLA-identical renal transplant recipients: immunosuppression, long-term complications, and survival.
|
Transplant Proc
|
2001
|
0.80
|
52
|
Methicillin-resistant Staphylococcus aureus infection in liver transplantation: a matched controlled study.
|
Transplant Proc
|
2005
|
0.80
|
53
|
Synchronous pancreas-kidney transplantation with portal venous and enteric exocrine drainage: outcome in 70 consecutive cases.
|
Transplant Proc
|
1998
|
0.80
|
54
|
Pancreas transplantation with portal venous drainage and enteric exocrine drainage offers early advantages without compromising safety or allograft function.
|
Transplant Proc
|
1995
|
0.79
|
55
|
Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year.
|
Transplantation
|
1996
|
0.79
|
56
|
Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy.
|
Transplant Proc
|
2005
|
0.79
|
57
|
De novo sarcomas in solid organ transplant recipients.
|
Transplant Proc
|
2002
|
0.79
|
58
|
Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal.
|
Transplant Proc
|
1997
|
0.79
|
59
|
Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.
|
Transplant Proc
|
1998
|
0.79
|
60
|
Outcomes of patients with rejection post-polyomavirus nephropathy.
|
Transplant Proc
|
2005
|
0.78
|
61
|
Hand-assisted laparoscopic live-donor nephrectomy.
|
J Am Coll Surg
|
2001
|
0.78
|
62
|
Transmission of donor cancer into cardiothoracic transplant recipients.
|
Surgery
|
2001
|
0.78
|
63
|
New scoring system identifies kidney outcome with radiation therapy in acute renal allograft rejection.
|
Int J Radiat Oncol Biol Phys
|
2000
|
0.78
|
64
|
Changes in urinary cytokine mRNA profile after successful therapy for acute cellular renal allograft rejection.
|
Transplant Proc
|
1995
|
0.78
|
65
|
Pediatric liver transplantation at the University of Chicago Hospitals.
|
Clin Transpl
|
1992
|
0.77
|
66
|
An analysis of hepatic retransplantation in children.
|
Transplantation
|
1998
|
0.77
|
67
|
Neurotoxicity of FK 506 in liver transplant recipients.
|
Transplant Proc
|
1993
|
0.77
|
68
|
Coadministration of tacrolimus and mycophenolate mofetil in stable kidney transplant patients: pharmacokinetics and tolerability.
|
J Clin Pharmacol
|
2000
|
0.77
|
69
|
Tc-NGA imaging in liver transplantation: preclinical studies.
|
Surgery
|
1987
|
0.77
|
70
|
African American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression.
|
Transplant Proc
|
2005
|
0.77
|
71
|
Central nervous system tumors in donors: misdiagnosis carries a high morbidity and mortality.
|
Transplant Proc
|
2005
|
0.77
|
72
|
Effect of corticosteroid withdrawal on tacrolimus and mycophenolate mofetil exposure in a randomized multicenter study.
|
Am J Transplant
|
2012
|
0.76
|
73
|
Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantation.
|
Transplant Proc
|
2005
|
0.76
|
74
|
Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity.
|
Am J Kidney Dis
|
1999
|
0.76
|
75
|
T lymphocyte activation following OKT3 treatment.
|
Curr Surg
|
1991
|
0.76
|
76
|
Use of polytetrafluoroethylene patch for temporary wound closure after pediatric liver transplantation.
|
Transplantation
|
1996
|
0.76
|
77
|
Chemotherapy for posttransplant lymphoproliferative disorder: the Israel Penn International Transplant Tumor Registry experience.
|
Transplant Proc
|
2005
|
0.76
|
78
|
Successful use of tacrolimus for initial rejection episodes after liver transplantation.
|
Transplant Proc
|
1998
|
0.76
|
79
|
Of mice and men: terminal complement inhibition with anti-C5 monoclonal antibodies.
|
Am J Transplant
|
2011
|
0.75
|
80
|
General surgery: liver transplantation.
|
West J Med
|
1985
|
0.75
|
81
|
Regulatory approval for new antihumoral therapies: addressing the barriers.
|
Am J Transplant
|
2011
|
0.75
|
82
|
Paired exchanges should be part of the solution to ABO incompatibility in living donor kidney transplantation.
|
Transplantation
|
1998
|
0.75
|
83
|
Control of risk factors for cardiovascular disease in long-term renal transplant recipients.
|
Transplant Proc
|
2001
|
0.75
|
84
|
Late complications in kidney-pancreas transplant recipients.
|
Transplant Proc
|
1995
|
0.75
|
85
|
Combined liver and kidney transplantation in children.
|
Transplantation
|
2000
|
0.75
|
86
|
Hepatic perfusion abnormalities after liver transplantation.
|
Cardiovasc Intervent Radiol
|
1985
|
0.75
|
87
|
The diaphragmatic vena cava cuff in hepatic transplantation.
|
Transplantation
|
1985
|
0.75
|
88
|
Laparoscopic live donor nephrectomy: rationale, techniques, and implications.
|
Semin Dial
|
2001
|
0.75
|
89
|
Impact of a liberalized donor acceptance policy on liver transplantation.
|
Transplant Proc
|
1997
|
0.75
|
90
|
Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation.
|
Transplant Proc
|
1996
|
0.75
|
91
|
Reversal of delayed hyperacute renal allograft rejection with a tacrolimus-based therapeutic regimen.
|
Transplant Proc
|
1998
|
0.75
|
92
|
Programmed cell death signaling via cell-surface expression of a single-chain antibody transgene.
|
Transplantation
|
2000
|
0.75
|
93
|
Retransplantation for failed hepatic allografts in children.
|
Transplant Proc
|
1997
|
0.75
|
94
|
Aggressive needle biopsy protocol prevents loss of renal allografts to undetected rejection during early posttransplant dysfunction.
|
Transplant Proc
|
1989
|
0.75
|
95
|
Liver transplantation at the University of Chicago.
|
Clin Transpl
|
1995
|
0.75
|
96
|
A simple technique for experimental hepatic vein catheterization in swine.
|
Lab Anim Sci
|
1986
|
0.75
|
97
|
Economic outcome of simultaneous pancreas kidney transplantation compared with kidney transplantation alone.
|
Transplant Proc
|
2001
|
0.75
|
98
|
Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation.
|
Transplant Proc
|
1998
|
0.75
|
99
|
Pilot study of early corticosteroid elimination after pancreas transplantation.
|
Transplant Proc
|
2005
|
0.75
|
100
|
Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression.
|
Transplant Proc
|
2005
|
0.75
|
101
|
Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy.
|
Transplant Proc
|
1997
|
0.75
|
102
|
Cyclosporine versus cyclosporine microemulsion in pediatric liver transplant recipients.
|
Transplant Proc
|
1998
|
0.75
|
103
|
Transplantation without steroids.
|
Transplant Proc
|
2002
|
0.75
|
104
|
Construction of a single-chain antibody derived from 5H7, a monoclonal antibody specific for a death signaling domain of human class I major histocompatibility complex.
|
Transplant Proc
|
1998
|
0.75
|
105
|
Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients.
|
Transplant Proc
|
1996
|
0.75
|
106
|
Stapled duodenal-cystic anastomosis in pancreas transplantation.
|
Transplantation
|
1988
|
0.75
|
107
|
Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection.
|
Transplantation
|
1996
|
0.75
|
108
|
Orthotopic porcine liver transplantation: operative technique.
|
J Surg Res
|
1985
|
0.75
|
109
|
Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach.
|
Transplant Proc
|
1998
|
0.75
|
110
|
Anesthetic, preoperative and postoperative considerations for liver transplantation in swine.
|
Lab Anim Sci
|
1986
|
0.75
|
111
|
Inhibition of T-cell activation by an anti-human class I MHC reactive monoclonal antibody occurs at a point distal to TCR-CD3 mediated signal transduction.
|
Transplant Proc
|
1995
|
0.75
|